Colinz Laboratories Ltd Financials
Company Logo

Colinz Laboratories Ltd Financial Statement

Colinz Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue1.81
Operating Expense1.59
Net Profit0.14
Net Profit Margin7.73
Earning Per Share0.54
EBIDTA0.23
Effective Tax Rate21.74

Colinz Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual7.03
Operating Expenses Annual6.49
Operating Profit Annual0.82
Interest Annual0.04
Depreciation0.13
Net Profit Annual0.49
Tax Annual0.16

Colinz Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning5.73
Cash Flow from Operations1.03
Cash Flow from Investing0.01
Cash Flow from Financing0.23
Cash Flow at the End7

Colinz Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)11.66
PBIT Margin (%)9.82
PBT Margin (%)-235.56
Net PROFIT Margin (%)6.97
Return On Networth / Equity (%)5.73
Return On Networth /Employed (%)7.70
Return On Assets (%)5.44
Total Debt / Equity (X)0.05
Asset Turnover Ratio (%)0.78

Colinz Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual1.58
Total Current Assets Annual8.74
Non Current Assets Annual2.62
Total Shareholders Funds Annual8.95
Total Assets Annual11.36

Colinz Laboratories Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 19, 2024, Colinz Laboratories Ltd has a market capitalization of 17.16 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Colinz Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.06.
In FY 2023 , Colinz Laboratories Ltd recorded a total revenue of approximately 7.03 Cr marking a significant milestone in the company's financial performance.
Colinz Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.0% annually, respectively..
Colinz Laboratories Ltd's current PE ratio is 35.02.
Colinz Laboratories Ltd's ROCE averaged 7.2% from the FY ending March 2022 to 2024, with a median of 7.2%. It peaked at 7.8% in March 2023, reflecting strong capital efficiency over the period..
Colinz Laboratories Ltd's latest EBIT is Rs. 0.69 Cr, surpassing the average EBIT of Rs. 0.63 Cr over the 5 years..